Breaking News Instant updates and real-time market news.

MCD

McDonald's

$186.69

-0.96 (-0.51%)

05:54
11/20/18
11/20
05:54
11/20/18
05:54

McDonald's management to meet with MKM Partners

Meeting to be held in Chicago on November 20 hosted by MKM Partners.

  • 20

    Nov

MCD McDonald's
$186.69

-0.96 (-0.51%)

10/24/18
WELS
10/24/18
NO CHANGE
Target $197
WELS
Outperform
McDonald's price target raised to $197 from $185 at Wells Fargo
Wells Fargo analyst Jon Tower raised his price target for McDonald's to $197 from $185 and reiterated an Outperform rating on the shares. In the context of a U.S. competitive environment that appears to be intensifying by the day, the company's multi-year, pro-active plan to build and grow sales and customer counts is demonstrating "strong progress."
10/24/18
KEYB
10/24/18
NO CHANGE
Target $195
KEYB
Overweight
McDonald's price target raised to $195 from $185 at KeyBanc
KeyBanc analyst Eric Gonzalez raised his price target for McDonald's to $195 from $185 on "strong" global momentum. The analyst believes the company has stemmed its losses at breakfast in the majority of markets and looks forward to new value and menu news in the coming weeks, which should help arrest traffic declines in those markets that continue to struggle. The analyst reiterates an Overweight rating on the shares.
10/24/18
RBCM
10/24/18
NO CHANGE
Target $190
RBCM
Outperform
McDonald's price target raised to $190 from $175 at RBC Capital
RBC Capital analyst David Palmer raised his price target on McDonald's to $190 and kept his Outperform rating after its "stronger than expected" Q3 results. The analyst believes that the company's restaurant remodeling activity positions it for re-acceleration in U.S. comps, with added improvements coming from its international segments. Palmer also raises his FY19 EPS view on McDonald's by 2c to $8.19 and also raises the FY19 revenue estimate to $20.82B from $20.67B.
11/09/18
COWN
11/09/18
NO CHANGE
Target $205
COWN
Outperform
McDonald's price target raised to $205 from $190 at Cowen
Cowen analyst Andrew Charles raised his price target on McDonald's to $205 from $190 as he believes the company is well positioned to deliver on 3% comps in 2019. He believes there is a greater chance for upside in 2019 if franchises can slow the pace of remodels, which is a potential outcome to settle franchisee concerns. Charles reiterated his Outperform rating on McDonald's shares.

TODAY'S FREE FLY STORIES

SKX

Skechers

$22.90

-0.61 (-2.59%)

05:52
12/17/18
12/17
05:52
12/17/18
05:52
Initiation
Skechers initiated  »

Skechers initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$102.30

-0.94 (-0.91%)

, ORTX

Orchard Therapeutics

$15.00

-0.01 (-0.07%)

05:49
12/17/18
12/17
05:49
12/17/18
05:49
Recommendations
Argenx, Orchard Therapeutics analyst commentary  »

Goldman starts Argenx at…

ARGX

Argenx

$102.30

-0.94 (-0.91%)

ORTX

Orchard Therapeutics

$15.00

-0.01 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$172.80

-3.07 (-1.75%)

05:48
12/17/18
12/17
05:48
12/17/18
05:48
Periodicals
Malaysian authorities file criminal charges against Goldman Sachs, WSJ says »

Malaysia's attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

$32.78

-1 (-2.96%)

05:47
12/17/18
12/17
05:47
12/17/18
05:47
Conference/Events
Alkermes management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

  • 31

    Jan

LULU

Lululemon

$119.13

-1.08 (-0.90%)

05:42
12/17/18
12/17
05:42
12/17/18
05:42
Upgrade
Lululemon rating change  »

Lululemon upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Jan

AXON

Axovant Sciences

$1.01

-0.12 (-10.62%)

05:36
12/17/18
12/17
05:36
12/17/18
05:36
Upgrade
Axovant Sciences rating change  »

Axovant Sciences upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPI

SPI Energy

$1.19

-0.02 (-1.65%)

05:36
12/17/18
12/17
05:36
12/17/18
05:36
Hot Stocks
SPI Energy receives delinquency notice from Nasdaq »

SPI Energy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$0.00

(0.00%)

05:35
12/17/18
12/17
05:35
12/17/18
05:35
Hot Stocks
Bombardier to supply a further 20 FLEXITY trams to Karlsruhe »

Global mobility solution…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$21.24

-2.25 (-9.58%)

05:32
12/17/18
12/17
05:32
12/17/18
05:32
Downgrade
Tenet rating change  »

Tenet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMR

Emerson

$60.45

-0.29 (-0.48%)

05:31
12/17/18
12/17
05:31
12/17/18
05:31
Downgrade
Emerson rating change  »

Emerson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFA

MFA Financial

$6.98

-0.01 (-0.14%)

05:27
12/17/18
12/17
05:27
12/17/18
05:27
Upgrade
MFA Financial rating change  »

MFA Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

05:27
12/17/18
12/17
05:27
12/17/18
05:27
Hot Stocks
Incyte, Innovent announce strategic collaboration, licensing agreement »

Incyte and Innovent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

CSL

Carlisle

$96.53

-1.69 (-1.72%)

05:26
12/17/18
12/17
05:26
12/17/18
05:26
Upgrade
Carlisle rating change  »

Carlisle upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:25
12/17/18
12/17
05:25
12/17/18
05:25
Hot Stocks
Roche SMA treatment risdiplam granted PRIME designation by EMA »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

  • 18

    Mar

SMG

Scotts Miracle-Gro

05:25
12/17/18
12/17
05:25
12/17/18
05:25
Upgrade
Scotts Miracle-Gro rating change  »

Scotts Miracle-Gro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFA

MFA Financial

$6.98

-0.01 (-0.14%)

05:24
12/17/18
12/17
05:24
12/17/18
05:24
Upgrade
MFA Financial rating change  »

MFA Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGI

Triumph Group

$13.23

0.13 (0.99%)

05:18
12/17/18
12/17
05:18
12/17/18
05:18
Upgrade
Triumph Group rating change  »

Triumph Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$82.34

-1.35 (-1.61%)

05:16
12/17/18
12/17
05:16
12/17/18
05:16
Upgrade
LyondellBasell rating change  »

LyondellBasell upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EC

Ecopetrol

$18.36

-0.33 (-1.77%)

, YPF

YPF

$14.38

0.03 (0.21%)

05:11
12/17/18
12/17
05:11
12/17/18
05:11
Recommendations
Ecopetrol, YPF, Petrobras analyst commentary  »

Ecopetrol price target…

EC

Ecopetrol

$18.36

-0.33 (-1.77%)

YPF

YPF

$14.38

0.03 (0.21%)

PBR

Petrobras

$13.40

-0.235 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$62.29

0.96 (1.57%)

05:04
12/17/18
12/17
05:04
12/17/18
05:04
Recommendations
Alaska Air analyst commentary  »

Alaska Air called a top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$17.58

-0.14 (-0.79%)

04:59
12/17/18
12/17
04:59
12/17/18
04:59
Initiation
Avaya initiated  »

Avaya initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$102.30

-0.94 (-0.91%)

04:57
12/17/18
12/17
04:57
12/17/18
04:57
Initiation
Argenx initiated  »

Argenx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORTX

Orchard Therapeutics

$15.00

-0.01 (-0.07%)

04:56
12/17/18
12/17
04:56
12/17/18
04:56
Upgrade
Orchard Therapeutics rating change  »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHW

Sherwin-Williams

$385.73

-0.075 (-0.02%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Upgrade
Sherwin-Williams rating change  »

Sherwin-Williams upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHN

Achillion

$3.12

0.035 (1.14%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Achillion to hold a conference call »

Dr. Stephen Zelenkofske,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.